SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001072613-23-000104
Filing Date
2023-02-13
Accepted
2023-02-13 16:08:24
Documents
1
Group Members
ARCH VENTURE FUND X OVERAGE, L.P.ARCH VENTURE PARTNERS X OVERAGE, L.P.ARCH VENTURE PARTNERS X, L.P.ARCH VENTURE PARTNERS X, LLCKEITH CRANDELLKRISTINA BUROWROBERT NELSENSTEVEN GILLIS

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND X, L.P. - PRIME MEDICINE, INC. -- SCH 13G arch-sch13g_18696.htm SC 13G 296408
  Complete submission text file 0001072613-23-000104.txt   298173
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 773-380-6600
ARCH Venture Fund X, L.P. (Filed by) CIK: 0001757011 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Subject) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93800 | Film No.: 23618428
SIC: 2836 Biological Products, (No Diagnostic Substances)